Balaglitazone
5-[[4-[(3-methyl-4-oxoquinazolin-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
Molecular Identity
Balaglitazone
5-[[4-[(3-methyl-4-oxoquinazolin-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
PubChem CID: 9889200
2D Structure
Properties
C20H17N3O4S
Molecular Formula
395.40
Molecular Weight
g/mol
395.0940
Exact Mass
Da
2.7
XLogP
Drug-like (Lipinski: < 5)
113
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
6
H-Bond Acceptors
674
Complexity
SMILES
Canonical SMILES
SMILES: CN1C(=NC2=CC=CC=C2C1=O)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4Isomeric SMILES
SMILES: CN1C(=NC2=CC=CC=C2C1=O)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4Synonyms(20)
Balaglitazone199113-98-9DRF-2593NN-2344balaglitazona5-({4-[(3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione4M1609828ODTXSID30870213balaglitazonum5-((4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)phenyl)methyl)-1,3-thiazolidine-2,4-dioneRefChem:116359DTXCID80817996Balaglitazone [INN]2,4-Thiazolidinedione, 5-[[4-[(3,4-dihydro-3-methyl-4-oxo-2-quinazolinyl)methoxy]phenyl]methyl]-DRF 2593;NN 2344
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Balaglitazone
Loading drug network...